1. Corporate Officers - C
2. Coiante Scott M

Insider Trading History of Coiante Scott M

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Coiante Scott M since 2018. This trader's CIK number is 1608536. At the time of last reporting, Coiante Scott M was the SVP, Chief Financial Officer of Lexicon Pharmaceuticals, Inc.. (stock ticker symbol LXRX). Also see all insider trading activities at Lexicon Pharmaceuticals, Inc..

Note that in the past Coiante Scott M also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Lexicon Pharmaceuticals, Inc. (LXRX) by Coiante Scott M

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2026	LXRX	0	$0	0	$0	160,237	$0

Yearly summary of insider trading at Agile Therapeutics Inc (AGRX) by Coiante Scott M

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2019	AGRX	0	$0	0	$0	33,570	$0
2018	AGRX	0	$0	0	$0	17,500	$0

Yearly summary of insider trading at Aprea Therapeutics, Inc. (APRE) by Coiante Scott M

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2019	APRE	2,500	$37,500	0	$0	0	$0

Insider trading activities at 3 companies by Coiante Scott M:

1. Lexicon Pharmaceuticals, Inc. (LXRX)

2. Agile Therapeutics Inc (AGRX)

3. Aprea Therapeutics, Inc. (APRE)

Table 1. Insider trading of Lexicon Pharmaceuticals, Inc. (LXRX) by Coiante Scott M

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2026-02-28	LXRX	Option Ex	160,237	.00	0

Table 2. Insider trading of Agile Therapeutics Inc (AGRX) by Coiante Scott M

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2019-01-25	AGRX	Option Ex	17,500	.00	0
2019-01-24	AGRX	Option Ex	16,070	.00	0
2018-01-25	AGRX	Option Ex	17,500	.00	0

Table 3. Insider trading of Aprea Therapeutics, Inc. (APRE) by Coiante Scott M

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2019-10-07	APRE	Buy	2,500	15.00	37,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Coiante Scott M (SVP, Chief Financial Officer of Lexicon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month